Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending February 2012. The report details a specific share repurchase transaction executed on February 10, 2012, in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share buyback activity:
- Shares Purchased: 425,000 Ordinary shares of 25 pence each.
- Price Range: Highest price paid was 1,424.0 pence per share; lowest price paid was 1,404.0 pence per share.
- Treasury Holdings: Post-transaction, the Company holds 501,157,927 shares in Treasury (9.02% of total issued share capital).
- Total Voting Rights: Including unsettled purchases, Treasury holdings represent 9.95% of total voting rights.
- Shares in Issue: 5,051,936,582 shares (excluding Treasury shares).
Material Changes
The filing does not provide comparative financial data or material changes regarding operational performance versus prior periods. The primary change reported is the reduction of outstanding shares through the acquisition of 425,000 shares for Treasury.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (501,157,927) against the latest public cap table.
- Confirm the calculation of total voting rights (9.95% held in Treasury including unsettled shares).
- Check the price paid per share (1,404.0 to 1,424.0 pence) against market trading data for February 10, 2012.
- Review the remaining authorization for share buybacks under the May 5, 2011 shareholder mandate.